Remission clone in acute myeloid leukemia shows growth advantage after chemotherapy but is distinct from leukemic clone.
暂无分享,去创建一个
Zhaolei Zhang | S. Ogawa | Kenichi Yoshida | Je-Jung Lee | Sayeon Cho | Hyeoung-Joon Kim | M. Shin | Deok-Hwan Yang | Jae-Sook Ahn | Yeo-Kyeoung Kim | Young-Chang Cho | TaeHyung Kim | Dennis (Dong Hwan) Kim | Seo-Yeon Ahn | S. Choi | Ja-yeon Lee | Seung-Yeon Jung | S. Jung | I. Kim | I. Kim | S. Jung
[1] L. Bullinger,et al. Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients. , 2019, Blood.
[2] D. Liang,et al. Genetic and Epigenetic Perturbations by DNMT3A-R882 Mutants Impaired Apoptosis through Augmentation of PRDX2 in Myeloid Leukemia Cells , 2018, Neoplasia.
[3] M. Dubé,et al. Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A. , 2018, Blood.
[4] P. A. Futreal,et al. Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] Markus G. Manz,et al. Molecular Minimal Residual Disease in Acute Myeloid Leukemia , 2018, The New England journal of medicine.
[6] B. Dörken,et al. Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis , 2018, Leukemia.
[7] W. Hiddemann,et al. Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia , 2017, Leukemia.
[8] J. Passweg,et al. Acute myeloid leukaemia genomics , 2017, British journal of haematology.
[9] Mingming Jia,et al. COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..
[10] Christopher A. Miller,et al. Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML. , 2016, Blood.
[11] S-H Jung,et al. Clonal dynamics in a single AML case tracked for 9 years reveals the complexity of leukemia progression , 2016, Leukemia.
[12] D. Grimwade,et al. Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. , 2016, Blood.
[13] Christopher A. Miller,et al. Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia. , 2015, JAMA.
[14] Margaret A. Goodell,et al. DNMT3A in haematological malignancies , 2015, Nature Reviews Cancer.
[15] Lincoln D. Stein,et al. Identification of pre-leukemic hematopoietic stem cells in acute leukemia , 2014, Nature.
[16] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[17] T. Naoe,et al. Gene mutations of acute myeloid leukemia in the genome era , 2013, International Journal of Hematology.
[18] Yong-mei Zhu,et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia , 2011, Nature Genetics.
[19] Augustin Ferrant,et al. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. , 2003, The New England journal of medicine.